VANGUARD PORTFOLIO MANAGEMENT LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 2100121
MALVERN, PA
Position in ESPR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,471,671
-30.0% QoQ
Ownership
0.960%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VANGUARD PORTFOLIO MANAGEMENT LLC holds $7,792,404,186 across 40 Drug Manufacturers - Specialty & Generic names. ESPR ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
23,860,445 | $1,714,611,577 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,919,429 | $1,040,004,215 | |
| 3 | VTRS |
Viatris Inc
|
54,282,080 | $861,999,430 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,974,083 | $838,331,948 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
22,672,312 | $557,965,598 | |
| 6 | ALKS |
Alkermes plc.
|
9,490,818 | $497,318,863 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
10,559,314 | $366,091,416 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
3,238,471 | $359,275,972 |
All Filings in ESPR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 2,471,671 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | — | 3,532,563 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||